Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.35
Bid: 30.00
Ask: 30.20
Change: 1.45 (5.02%)
Spread: 0.20 (0.667%)
Open: 28.00
High: 31.05
Low: 28.00
Prev. Close: 28.90
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update re: Noteholder Consent Request

11 Nov 2020 08:10

RNS Number : 9658E
Marston's PLC
11 November 2020
 

 

 

11 November 2020

MARSTON'S PLC

("Marston's" or "the Group")

 

COVID-19 Update re: Noteholder Consent Request

 

As previously announced in May this year, the Group received overwhelming support from its bondholders for certain waivers and amendments for 2020 within its Secured Estate, due to the Government's mandate to temporarily close pubs and restaurants across the UK from 20 March to 4 July 2020 in response to the COVID-19 pandemic.

As we guided in our trading update on 15 October, Marston's outperformed the market in the 13 weeks to 3 October. The Group was able to successfully reopen approximately 99% of its pubs, albeit under varying degrees of trading restrictions. Encouragingly, like for like sales at the Group's managed and franchised pubs were 90% of the previous financial year during the corresponding period and during August, like for like sales increased 6%, illustrating the Group's ability to reopen and trade its pubs well in spite of the continued restrictions imposed on the hospitality sector. Cash generation was also ahead of expectations.

Marston's announces today that it has formally asked the holders of its Secured Class A Notes for a limited number of further technical waivers during the first half of 2021, as a precautionary measure following the renewed lockdown restrictions introduced in Wales on 23 October, and in England last week. The waivers being requested are required solely as a consequence of the enforced temporary re-closure of its pubs in England by the UK Government as a result of the COVID--19 pandemic measures, together with the continued uncertainty with regard to further potential lockdowns over the winter months. Noteholders have been asked to respond by 1 December and a meeting is scheduled for 3 December 2020.

The financial and liquidity position of Marston's and its subsidiaries remains strong. As previously announced, the Group did not need to utilise the additional £70 million bank facility secured in May. In addition, the sale of Marston's Beer company to the joint venture with Carlsberg UK Holdings Limited completed in October, generating initial net proceeds of around £230 million, further reducing the Group's bank debt.

However, given the prevailing uncertain outlook, management are continuing to take a prudent approach and therefore believe it is appropriate to seek the waivers requested to provide the Security Group with maximum flexibility over the coming months should that be required.

In addition, and as previously announced, to further ensure that liquidity is maximised within the Security Group, it has agreed not to make any distributions to the wider Marston's Group until after 2 October 2021 at the earliest.

 

ENQUIRIES:

Marston's PLC Tel: 01902 329516

Instinctif Partners Tel: 020 7457 2010/2005

Ralph Findlay, Chief Executive Officer

Justine Warren

Andrew Andrea, Chief Financial and Corporate Development Officer

Matthew Smallwood

 

NOTES TO EDITORS

· Marston's is a leading pub operator with a 40% holding in Carlsberg Marston's Beer Company

· It has an estate of 1,379 pubs situated nationally, comprising managed, franchised and leased pubs.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAPFFFENEFEA
Date   Source Headline
28th Mar 20242:50 pmRNSDirector/PDMR Shareholding
15th Mar 202410:15 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSSuccession plan to appoint new Chair of the Board
7th Mar 202410:03 amRNSDirector Declaration
6th Mar 20248:35 amRNSDirector/PDMR Shareholding
5th Mar 20244:24 pmRNSDirector/PDMR Shareholding
1st Mar 202412:58 pmRNSTotal Voting Rights
9th Feb 20248:40 amRNSHolding(s) in Company
7th Feb 20244:08 pmRNSHolding(s) in Company
2nd Feb 202411:14 amRNSDirector/PDMR Shareholding
1st Feb 20244:26 pmRNSHolding(s) in Company
31st Jan 20241:52 pmRNSHolding(s) in Company
23rd Jan 20241:30 pmRNSResult of AGM
23rd Jan 20247:00 amRNSTrading for the 16-week period to 20 January 2024
9th Jan 20241:57 pmRNSBlock listing Interim Review
20th Dec 20234:16 pmRNSAnnual Financial Report
5th Dec 20237:00 amRNSPRELIMINARY RESULTS
1st Dec 20232:30 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSDirectorate Change
22nd Nov 20232:02 pmRNSHolding(s) in Company
17th Nov 20237:00 amRNSMarston’s PLC appoints Justin Platt as new CEO
11th Oct 20237:00 amRNSTrading update for the 52 weeks to 30 Sep 2023
15th Aug 20233:36 pmRNSHolding(s) in Company
1st Aug 20239:30 amRNSHolding(s) in Company
26th Jul 20234:29 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSTrading update for the 42 weeks to 22 July 2023
10th Jul 20233:21 pmRNSBlock listing Interim Review
4th Jul 20232:18 pmRNSNotification of Trading Update Date
29th Jun 202310:26 amRNSDirector/PDMR Shareholding
28th Jun 20235:03 pmRNSDirector/PDMR Shareholding
28th Jun 20234:54 pmRNSDirector/PDMR Shareholding
27th Jun 20234:11 pmRNSDirector/PDMR Shareholding
26th Jun 20232:23 pmRNSDirector/PDMR Shareholding
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.